Capsule Sponge Study in Eosinophilic Oesophagitis
NCT06501274
Digestive System Diseases, Eosinophilia
Stevenage, Hertfordshire, United Kingdom
View Trial DetailsNCT Number: NCT03382678
The purpose of this study is to validate the online cohort of EGID patients enrolled in the RDCRN CEGIR CR. In order to achieve this objective, the investigators will determine the agreement between self-reported EGID information by the enrollees and their physician's report and medical records. All participants enrolled in the RDCRN CEGIR CR with EGIDs will be invited via email to participate in this study.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
All individuals with EGID and enrolled in the RDCRN CEGIR CR will be invited to participate in this survey. As of 04/28, 1567 EGID patients have enrolled in CEGIR CR [EoE=1,217, EG=56, EGE=65, EC=52; multiple diseases=177]
The survey will be conducted through a pre-designed questionnaire. The questionnaire will be sent to participants via an introductory email wherein subjects will be informed about the purpose of this study. The questionnaire will gather self-reported clinical information (such as diagnosis, endoscopic procedures, histological findings in mucosal biopsies, and therapeutic plan). Consent will be obtained from participants to contact their physicians and allow their physicians to share relevant clinical information from their medical records.
Physicians identified by participants will be emailed a website link which will take them to a questionnaire. This questionnaire is designed to gather relevant information as documented in the patient's clinical records. Physicians will be able to submit the information online. It is anticipated that responding to this questionnaire would take less than 10 minutes of their time.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 months
Assess the validity of self-reported EGID diagnosis by comparing to physician reports.
Children's Hospital Medical Center, Cincinnati
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06501274
Digestive System Diseases, Eosinophilia
Stevenage, Hertfordshire, United Kingdom
View Trial DetailsNCT01988285
Digestive System Diseases, Eosinophilia
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07093008
Digestive System Diseases, Eosinophilia
Madison, Wisconsin, United States
View Trial DetailsNCT05774184
Digestive System Diseases, Eosinophilia
Birmingham, Alabama, United States
View Trial Details